antidiabetic agent

antidiabetic agent

Any agent intentionally used to improve glucose control (e.g., efficiency of glucose utilisation).
 
Types
▪ Parenteral (e.g., insulin, exenatide, liraglutide and pramlintide).
▪ Oral hypoglycaemic agents.
References in periodicals archive ?
HONG KONG, Nov 24, 2015 - (ACN Newswire) - Uni-Bio Science Group Limited ("Uni-Bio" or the "Group"; HKEx code: 690) today announced that it will acquire exclusive global rights to manufacture and commercialise mitiglinide, a new oral antidiabetic agent, from Jiangsu Hansoh Pharmaceutical Co.
Nearly all elderly patients with type 2 diabetes will be started on some antidiabetic agent at some point, Dr.
A comparative study of flavonoid analoges on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11 beta-hydroxysteriod dehydrogenase type 1 inhibition.
They recommended use of Aloe vera as an antidiabetic agent (25,26,27).
The PROactive Study (Prospective Pioglitazone Clinical Trial In Macrovascular Events Study) showed that ACTOS (generic name: pioglitazone HCI), an oral antidiabetic agent, can reduce the risk of developing and dying of cardiovascular diseases including heart attack and strokes in type 2 diabetics.
For example, patients with newly diagnosed, but untreated, diabetes, with no evidence of end organ damage, would be used to test a new antidiabetic agent.
There are situations where combining insulin with another antidiabetic agent gives the best results.
In addition, metformin is also the only antidiabetic agent that is associated with weight loss, or at least weight stabilization.
In other studies, metabolic syndrome, obesity, and insulin resistance have been associated with poorer tumor biology and the use of the antidiabetic agent metformin has been associated with decreased breast cancer incidence and perhaps improved outcome following diagnosis.
littorale is a potent antidiabetic agent without any toxic effect at this particular dose (1.
Nevertheless, a once-weekly antidiabetic agent clearly represents an attractive option for type 2 diabetes patients, and physicians expect the drug to be a welcome addition to their armamentarium.
In light of these data, physicians may want to look at metformin when choosing an oral antidiabetic agent for their patients, Dr.